Trials / Completed
CompletedNCT01808547
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 268 (actual)
- Sponsor
- Sun Pharmaceutical Industries Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the ocular safety, tolerability and efficacy of topical administration of ISV-303 compared with Durasite Vehicle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ISV-303 | 0.075% bromfenac in DuraSite dosed BID |
| OTHER | DuraSite Vehicle | DuraSite vehicle dosed BID |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2013-03-11
- Last updated
- 2021-11-19
- Results posted
- 2016-07-13
Source: ClinicalTrials.gov record NCT01808547. Inclusion in this directory is not an endorsement.